SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros. Discovery is at the center of an intense acquisition battle, with Paramount Skydance actively pursuing a significant all-cash bid against Netflix's mixed cash-and-stock offer. The community is divided, debating the superior value of each proposal while considering cash certainty, regulatory hurdles, and the valuation implications of a planned content spin-off.

Aeva Technologies, Inc. develops sensing paradigm for autonomous vehicles and robotics. The firm offers drones, robotics, vehicle technology, and virtual and augmented reality products. The company was founded by Soroush Salehian Dardashti and Mina Rezk in 2017 and is headquartered in Mountain View, CA.

Aeva Technologies Inc

Aeva Technologies is generating significant market buzz after its 4D LiDAR technology was selected as a reference sensor for NVIDIA's DRIVE Hyperion autonomous vehicle platform, alongside securing an exclusive production contract with a major European passenger OEM. This dual validation is fueling strong bullish sentiment around its role in future automated driving and Physical AI applications, though skepticism persists regarding the company's path to profitability and potential share dilution.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is a focal point of market conversation due to its ongoing pursuit to acquire Warner Bros. Discovery, recently reiterating its all-cash offer backed by a significant personal financing guarantee. This move intensifies competition with Netflix's rival bid, sparking community debate over which proposal offers superior value and a clearer path for Warner Bros. Discovery shareholders amidst a landscape of evolving media consolidation and streaming industry dynamics. Many are discussing the implications for future content and potential AI integration, alongside regulatory considerations for media mergers.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is trending amid intense market speculation surrounding its valuable globally harmonized spectrum (Band n53) and advanced XCOM RAN technology. Community discussion is primarily driven by anticipation of strategic partnerships or a potential acquisition, frequently mentioning major industry players and observing ongoing FCC regulatory developments concerning spectrum usage.

Brevis

Recent listings on several major exchanges, including Coinbase, Binance, and ByBit, are driving significant attention to Brevis (BREV) and its Zero Knowledge Proof (ZKP) token utility. The community is actively discussing BREV as a strong contender within the heating ZKP market and the broader RWA trend. Many view its current movements as a prime buying opportunity amidst this increased visibility.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

DOG (Bitcoin) is trending with its loyal "DOG Army" celebrating recent bullish sentiment and strategic accumulation by public entities, signaling growing institutional interest in Bitcoin-native assets. The community champions DOG as the premier decentralized memecoin, highlighting its fair launch and direct integration with Bitcoin's security as key differentiators. This positions DOG as a high-conviction play poised to dominate the meme coin sector, leveraging the robustness of the Bitcoin ecosystem.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy (MSTR) remains a highly debated stock, primarily driven by Bitcoin's fluctuating price and recent confirmation of its continued inclusion in MSCI indexes, which has eased some previous market concerns. Despite this, community sentiment is sharply divided, with bulls anticipating significant gains as a leveraged Bitcoin play, while bears focus on ongoing share dilution and MSTR's perceived underperformance.

The Aircoin memecoin was born from a viral Twitter post from March, 2014 which proclaimed the following:   Evolution: 1. Aircoin 2. Fartcoin 3. Artcoin  Aircoin was launched in August, 2025 and CTO'd twice, with the second CTO team bringing vast experience and expertise to the project. The team includes industry veterans and visual arts professionals.  Aircoin is destined for greatness as a premier memecoin on the BONK.fun platform.

aircoin

Aircoin is trending strongly driven by its "AirLock" initiative, which has rapidly seen a substantial portion of its token supply locked by the community, indicating robust supply control. This innovative approach, alongside an active community boasting organic growth and a USD1-paired liquidity pool, is fueling highly bullish sentiment. Many in the community are also energized by recent celebrity interest and a shared vision for Aircoin's long-term prominence.

Costco Wholesale Corp. engages in the provision of operation of membership warehouses through wholly owned subsidiaries. It operates through the following geographical segments: United States, Canada, and Other International Operations. The company was founded by James D. Sinegal and Jeffrey H. Brotman in 1983 and is headquartered in Issaquah, WA.

Costco Wholesale Corp

Costco is trending following its strong December sales report, which showcased solid growth and particularly robust international segment performance. The community is also closely watching for a potential Supreme Court ruling on tariffs, which many believe could provide a substantial financial benefit to the company. This news, combined with recent analyst upgrades, is driving bullish sentiment despite some ongoing valuation debates.

The Kraft Heinz Co. engages in the manufacture and market of food and beverage products. It operates through the North America and International geographical segments. The company was founded on July 2, 2015, and is headquartered in Pittsburgh, PA.

Kraft Heinz Co

Kraft Heinz is actively discussed following its announcement to split into two independent companies by 2026, with a new CEO recently appointed to lead this strategic shift. While many investors see this and the stock's significant dividend yield as a deep value opportunity and a potential turnaround for the consumer staples giant, others remain skeptical, citing past performance, shifting consumer tastes, and even public criticism from major shareholder Warren Buffett. The community is sharply divided on whether the impending separation will unlock significant value or present new challenges for the company.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Assembly Biosciences, Inc. (NASDAQ:ASMB) Receives Average Rating of "Moderate Buy" from Analysts

Assembly Biosciences, Inc. (NASDAQ:ASMB - Get Free Report) has been given an average recommendation of "Moderate Buy" by the eight analysts that are covering the firm, MarketBeat Ratings reports. One...

Assembly Biosciences (NASDAQ:ASMB) Trading 4% Higher - Here's What Happened

Assembly Biosciences (NASDAQ:ASMB) Trading 4% Higher - Here's What Happened...

Ellsworth Advisors LLC Acquires New Holdings in Assembly Biosciences, Inc. $ASMB

Ellsworth Advisors LLC bought a new stake in Assembly Biosciences, Inc. (NASDAQ:ASMB - Free Report) during the third quarter, according to the company in its most recent 13F filing with the...

Assembly Biosciences (NASDAQ:ASMB) Stock Price Down 6% - What's Next?

Assembly Biosciences (NASDAQ:ASMB) Stock Price Down 6% - Should You Sell...

GILD Exercises Option to License Assembly Bio's Herpes Programs

Gilead exercises its option to license ASMB's HSV programs for developing long-acting candidates, ABI-1179 & ABI-5366, for recurrent genital herpes.

<ul class="summary-bullets"><li>Gilead will advance the clinical development and commercialization of the programs and Assembly Bio will receive a $35 million payment for Gilead’s exercise of the combined HSV program option.</li><li>H.C. Wainwright believes Gilead's opt-in "significantly de-risks the programs and provides Assembly with a strong financial foundation to execute across its pipeline of next-generation antivirals."</li><li>According to Gilead, over four million people in the U.S. and major European countries experience recurrent genital herpes.</li></ul>Shares of Assembly Biosciences Inc closed up 3% on Monday after Gilead Sciences exercised the option to license the company’s programs for recurrent genital herpes in a move applauded by Wall Street. &nbsp;The programs<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.gilead.com/news/news-details/2025/gilead-sciences-exercises-option-to-license-assembly-biosciences-helicase-primase-inhibitor-programs-for-recurrent-genital-herpes"> include</a> investigational candidates ABI-1179 and ABI-5366. Gilead will advance the clinical development and commercialization of the programs under its ongoing collaboration with Assembly Bio which was inked in 2023 and spans 12 years. Assembly Bio will receive a $35 million payment for Gilead’s exercise of the combined HSV program option and remains eligible for up to $330 million in regulatory and commercial milestones, as well as tiered royalties on net sales.H.C. Wainwright analyst Patrick Trucchio subsequently reiterated a ‘Buy’ rating on Assembly Biosciences (ASMB) with a $50 price target. The analyst believes Gilead's opt-in "significantly de-risks the programs and provides Assembly with a strong financial foundation to execute across its pipeline of next-generation antivirals."<h2 class="st-heading-2">About The Programs</h2>Genital herpes is a common sexually transmitted infection (STI) caused by the herpes simplex virus (HSV), leading to painful blisters and sores around the genitals or anus, though many people have mild or no symptoms and don't know they're infected. Spread through skin-to-skin contact, especially during sex, the virus stays in the body, causing recurring outbreaks triggered by stress, illness, or fatigue.According to Gilead, over four million people in the U.S. and major European countries experience recurrent genital herpes. No new therapies have been approved for HSV in the U.S. or Europe for more than 25 years, the company noted.ABI-1179 and ABI-5366 are novel long-acting inhibitors of viral helicase-primase, an enzyme essential for herpes virus replication. Positive interim Phase 1b data for ABI-5366 and ABI-1179 demonstrated strong antiviral activity and improvements in clinical outcomes, including significant reduction in virus-positive lesions, the company noted. Both compounds also exhibit pharmacokinetic and safety profiles supportive of once-weekly oral dosing.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around<a href="https://stocktwits.com/symbol/ASMB"> ASMB </a>rose from ‘bearish’ to ‘neutral’ territory over the past 24 hours, while message volume rose from ‘low’ to ‘normal’ levels.Sentiment around GILD stayed within the 'neutral' territory in the meantime.<a href="https://stocktwits.com/symbol/GILD">Shares of GILD</a> have risen nearly 34% this year while ASMB shares have more than doubled.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/spacex-rival-ula-ceo-tory-bruno-steps-down/cLeFtcyREub">SpaceX Rival ULA CEO Tory Bruno Steps Down After 12 Years — Says ‘My Work Here Is Now Complete’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

In this photo illustration, the Gilead Sciences company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

Assembly Biosciences Stock Jumps After Wall Street Says Gilead Opt-In ‘Significantly De-Risks’ Genital Herpes Programs

Gilead Sciences exercised the option to license Assembly Biosciences’ programs for recurrent genital herpes, including investigational candidates ABI-1179 and ABI-5366.

Equity

Gilead Sciences exercised the option to license Assembly Biosciences’ programs for recurrent genital herpes, including investigational candidates ABI-1179 and ABI-5366.


Assembly Biosciences (NASDAQ:ASMB) Sees Strong Trading Volume - Should You Buy?

Assembly Biosciences (NASDAQ:ASMB) Sees Strong Trading Volume - What's Next...

Assembly Biosciences' (ASMB) "Buy" Rating Reiterated at HC Wainwright

HC Wainwright reaffirmed a "buy" rating and set a $50.00 target price on shares of Assembly Biosciences in a report on Monday...

Gilead Sciences Exercises Option to License Assembly Biosciences Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes

Gilead Sciences, Inc. (Nasdaq: GILD) and Assembly Biosciences, Inc. (Nasdaq: ASMB), today announced Gilead has exercised its combined option to exclusively license Assembly Bios herpes simplex virus...

Assembly Biosciences, Inc. (NASDAQ:ASMB) Given Average Recommendation of "Moderate Buy" by Analysts

Shares of Assembly Biosciences, Inc. (NASDAQ:ASMB - Get Free Report) have received an average rating of "Moderate Buy" from the eight brokerages that are covering the firm, Marketbeat Ratings...

Assembly Biosciences, Inc. is a biotechnology company that focuses on developing small molecule antiviral therapeutics for serious viral diseases. Its lead programs, ABI-5366 and ABI-1179, long-acting helicase-primase inhibitors, are in clinical development for recurrent genital herpes. The company is partnered with Gilead Sciences to advance current and future antiviral programs across herpesviruses, HBV, and HDV. Assembly Biosciences was founded in 2005 and is headquartered in South San Francisco, CA.

Assembly Biosciences Inc

Yes — Rates Move Meaningfully Lower

Short-Term Dip, No Lasting Impact

No — Mostly Political Noise

Other – Comment Below

President Trump says he’s directing $200 billion into mortgage bond purchases to bring down rates and improve housing affordability. With questions around execution, authority, and real market impact, do you think this move will actually lower mortgage rates in 2026?

Will Trump’s Mortgage Bond Plan Actually Lower Rates in 2026?

ASMB
Assembly Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ASMB News

ASMBAssembly Biosciences Inc